Search Results - "LERANG, F"

Accuracy of Seven Different Tests for the Diagnosis of Helicobacter pylori Infection and the Impact of H2-Receptor Antagonists on Test Results by Lerang, F, Moum, B, Mowinckel, P, Haug, J B, Ragnhildstveit, E, Berge, T, Bjørneklett, A

“…Background: In this study we compared the accuracy of seven diagnostic tests in diagnosing Helicobacter pylori infection. Methods: Over 1 year 351 consecutive…”
Get full text

Accuracy of IgG Serology and Other Tests in Confirming Helicobacter pylori Eradication by LERANG, F, HAUG, J. B, MOUM, B, MOWINCKEL, P, BERGE, T, RAGNHILDSTVEIT, E, BJØRNEKLETT, A

“…Background: In this study we assessed the accuracy of IgG serology and other tests in confirming Helicobacter pylori eradication. Methods: The outcome of…”
Get full text

Highly effective twice-daily triple therapies for Helicobacter pylori infection and peptic ulcer disease: does in vitro metronidazole resistance have any clinical relevance? by Lerang, F, Moum, B, Haug, J B, Tolås, P, Breder, O, Aubert, E, Høie, O, Søberg, T, Flaaten, B, Farup, P, Berge, T

“…To compare cure rates of Helicobacter pylori (H. pylori) infection, ulcer healing, and side effects of three simplified regimens of triple therapy in patients…”
Get more information

Accuracy of Seven Different Tests for the Diagnosis of Helicobacter pylori Infection and the Impact of H 2 -Receptor Antagonists on Test Results by F. LERANG, B. MOUM, P. MOWINCKEL, J

Get full text

Laboratory handling of Helicobacter pylori critically influences the results of in-vitro metronidazole resistance determination by Henriksen, T.H., Lerang, F., Lia, A., Schøyen, R., Thoresen, T., Berge, T., Ragnhildstveit, E., Tveten, Y., Berstad, A.

“…In-vitro metronidazole resistance rates of Helicobacter pylori determined by Etest are high, and the predictive value of metronidazole resistance is low. It…”
Get full text

P636 Long-term outcome of anti-tumour necrosis factor treatment in inflammatory bowel disease: A real-life observational study at Østfold Central Hospital, Norway by Lerang, F, Gunther, E, Henriksen, M, Jelsness-Jørgensen, L P

“…Abstract Background Anti-tumour necrosis factor (a-TNF) is an established treatment for moderate to severe Crohn disease (CD) and ulcerative colitis (UC)…”
Get full text

Simplified 10-day bismuth triple therapy for cure of Helicobacter pylori infection : Experience from clinical practice in a population with a high frequency of metronidazole resistance by LERANG, F, MOUM, B, RAGNHILDSTVEIT, E, SANDVEI, P. K, TOLAS, P, WHIST, J. E, HENRIKSEN, M, HAUG, J. B, BERGE, T

“…To evaluate the cure rate of Helicobacter pylori infection, including the impact of in vitro metronidazole resistance (M-R), and the side effects of a…”
Get full text

A comparison between omeprazole-based triple therapy and bismuth-based triple therapy for the treatment of Helicobacter pylori infection: a prospective randomized 1-yr follow-up study by Lerang, F, Moum, B, Ragnhildstveit, E, Haug, J B, Hauge, T, Tolås, P, Aubert, E, Henriksen, M, Efskind, P S, Nicolaysen, K, Søberg, T, Odegaard, A, Berge, T

“…To compare the efficacy and side effects of standard bismuth triple therapy with those of omeprazole-based triple therapy in patients with Helicobacter pylori…”
Get more information

P408 Long-term efficacy of infliximab in patients with ulcerative colitis – an observational study from a single center in Norway by Lerang, F., Henriksen, M., Jelsness-Jørgensen, L.-P.

Get full text

P368 Vedolizumab in inflammatory bowel disease: a retrospective single-centre study by Larsson, C, Henriksen, M, Jelsness-Jørgensen, L-P, Rekvin, A, Lerang, F

“…Abstract Background Vedolizumab is an integrin receptor antagonist used when anti-TNF treatment has failed or is contraindicated in moderate to severe Crohn’s…”
Get full text

Highly Effective Second-Line Anti-Helicobacter pylori Therapy in Patients with Previously Failed Metronidazole-Based Therapy by Lerang, F., Moum, B., Haug, J. B., Berge, T., Tolas, P., Sandvei, P. K., Torp, R., Tønnesen, T.

“…Background: In this study we compared the cure rates of two clarithromycin-based regimens in patients in whom anti-Helicobacter pylori therapy had previously…”
Get full text

Current concepts in the management of Helicobacter pylori infection—The Maastricht 2‐2000 Consensus Report by Malfertheiner, P., Mégraud, F., O'Morain, C., Hungin, A. P. S., Jones, R., Axon, A., Graham, D. Y., Tytgat, G.

“…Significant progress and new insights have been gained in the 4 years since the first Maastricht Consensus Report, necessitating an update of the original…”
Get full text

Argon plasma coagulation--a new method in therapeutic endoscopy by Hauge, T, Moum, B, Sandvei, P, Lerang, F, Ravneng, P

“…By argon plasma coagulation (APC), a current is applied to tissues as ionised gas. Special probes have recently been developed for applying the gas through…”
Get full text

Assessment of the need of 24-hour availability of endoscopy by Moum, B, Hauge, T, Lerang, F, Sandvei, P, Henriksen, M, Pettersen, T

“…Endoscopy is the cornerstone of the diagnosis and treatment of acute conditions in the upper part of the gastrointestinal tract. The need for 24-hour…”
Get full text

Simplified 10-day bismuth triple therapy for cure of Helicobacter pylori infection: Experience from clinical practice in a population with a high frequency of metronidazole resistance by Lerang, F., Mourn, B., Ragnhildstveit, E., Sandvei, P.K., Tols, P., Whist, J.E., Henriksen, M., Haug, J.B., Berge, T.

“…Objective: To evaluate the cure rate of Helicobacter pylori infection, including the impact of in vitro metronidazole resistance (M-R), and the side effects of…”
Get full text

Simplified 10-Day Bismuth Triple Therapy for Cure ofHelicobacter pyloriInfection: Experience From Clinical Practice in a Population With a High Frequency of Metronidazole Resistance by Lerang, F, Mourn, B, Ragnhildstveit, E, Sandvei, P K, Tolås, P, Whist, J E, Henriksen, M, Haug, J B, Berge, T

Get full text

Treatment of Helicobacter pylori infection by Lygren, I, Andersen, L P, Lerang, F, Kleveland, P M, Farup, P, Vatn, M, Aursnes, I

“…The article presents information gained from a survey among Norwegian hospitals in March 1997 concerning their treatment of infections with Helicobacter…”
Get more information

Evaluering av behovet for døgnkontinuerlig endoskopitilbud by Moum, Bjørn, Hauge, Truls, Lerang, Frode, Sandvei, Per, Henriksen, Magne, Pettersen, Torkil

Get full text

Alternative treatment of Helicobacter pylori infections by Lerang, F, Moum, B, Ragnhildstveit, E

Get more information

Epidemiologic aspects of Bechterew's disease by Gran, J T, Lerang, F, Laegreid, I K, Hansen, J, Husby, G, Hordvik, M

Get more information